Literature DB >> 16050051

Schedules of controlled substances: placement of pregabalin into schedule V. Final rule.

.   

Abstract

This final rule is issued by the Deputy Administrator of the Drug Enforcement Administration (DEA) to place the substance pregabalin [(S)-3-(aminomethyl)-5-methylhexanoic acid], including its salts, and all products containing pregabalin into Schedule V of the Controlled Substances Act (CSA). As a result of this rule, the regulatory controls and criminal sanctions of Schedule V will be applicable to the manufacture, distribution, dispensing, importation and exportation of pregabalin and products containing pregabalin.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16050051

Source DB:  PubMed          Journal:  Fed Regist        ISSN: 0097-6326


  14 in total

1.  Earlier discovery of pregabalin's dependence potential might have been possible.

Authors:  Ola Caster; I Ralph Edwards; G Niklas Norén; Marie Lindquist
Journal:  Eur J Clin Pharmacol       Date:  2010-10-23       Impact factor: 2.953

2.  Pregabalin abuse and dependence in Germany: results from a database query.

Authors:  Maximilian Gahr; Roland W Freudenmann; Christoph Hiemke; Makus A Kölle; Carlos Schönfeldt-Lecuona
Journal:  Eur J Clin Pharmacol       Date:  2013-01-05       Impact factor: 2.953

3.  Preliminary Evidence of Pregabalin Misuse among Prescription and/or Illicit Opioid (Mis)users.

Authors:  Mance E Buttram; Steven P Kurtz
Journal:  J Psychoactive Drugs       Date:  2020-02-27

4.  Gabapentin drug misuse signals: A pharmacovigilance assessment using the FDA adverse event reporting system.

Authors:  Rachel Vickers-Smith; Jiangwen Sun; Richard J Charnigo; Michelle R Lofwall; Sharon L Walsh; Jennifer R Havens
Journal:  Drug Alcohol Depend       Date:  2019-11-02       Impact factor: 4.492

5.  Pregabalin abuse among opiate addicted patients.

Authors:  Martin Grosshans; Tagrid Lemenager; Christian Vollmert; Nina Kaemmerer; Rupert Schreiner; Jochen Mutschler; Xenija Wagner; Falk Kiefer; Derik Hermann
Journal:  Eur J Clin Pharmacol       Date:  2013-08-30       Impact factor: 2.953

Review 6.  Gabapentin misuse, abuse and diversion: a systematic review.

Authors:  Rachel V Smith; Jennifer R Havens; Sharon L Walsh
Journal:  Addiction       Date:  2016-03-18       Impact factor: 6.526

7.  Inappropriate Preoperative Gabapentinoid Use Among Patients With Carpal Tunnel Syndrome.

Authors:  Jessica I Billig; Erika D Sears; Vidhya Gunaseelan; Katherine B Santosa; Theodore J Iwashyna; Michael J Englesbe; Chad M Brummett; Jennifer F Waljee
Journal:  J Hand Surg Am       Date:  2020-05-30       Impact factor: 2.230

Review 8.  Pregabalin for neuropathic pain based on recent clinical trials.

Authors:  Brett R Stacey; Jon N Swift
Journal:  Curr Pain Headache Rep       Date:  2006-06

9.  Pregabalin Misuse and Abuse in Jordan: a Qualitative Study of User Experiences.

Authors:  Amneh Al-Husseini; Mayyada Wazaify; Marie Claire Van Hout
Journal:  Int J Ment Health Addict       Date:  2017-09-15       Impact factor: 3.836

Review 10.  Abuse of Prescription Drugs in the Context of Novel Psychoactive Substances (NPS): A Systematic Review.

Authors:  Fabrizio Schifano; Stefania Chiappini; John M Corkery; Amira Guirguis
Journal:  Brain Sci       Date:  2018-04-22
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.